SCHEMBL5528618

SCHEMBL5528618

CNS(=O)(=O)c1cccc(OC)c1C#N

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.46
SLC22A12 Q96S37 2/20 0.46
CCR4 P51679 1/20 0.44
NPC1 O15118 2/20 0.43
RAB9A P51151 1/20 0.43
ALDH1A1 P00352 4/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C19 P33261 1/20 0.42
PKM P14618 1/20 0.42
MAPT P10636 2/20 0.40
LMNA P02545 1/20 0.40
CYP2C9 P11712 1/20 0.40
HTR6 P50406 1/20 0.39
RXFP1 Q9HBX9 1/20 0.37
SGK1 O00141 1/20 0.37
TSHR P16473 1/20 0.37
POLB P06746 1/20 0.36
SLC40A1 Q9NP59 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30753930 0.84 ALDH1A1 (0.50) L3MBTL1SLC22A12CCR4NPC1RAB9A
SCHEMBL162306 0.84 ALDH1A1 (0.50) L3MBTL1SLC22A12CCR4NPC1RAB9A
SCHEMBL29572114 0.82 SLC22A12 (0.40) L3MBTL1SLC22A12CCR4ALDH1A1MAPT
SCHEMBL168370 0.82 SLC22A12 (0.40) L3MBTL1SLC22A12CCR4ALDH1A1MAPT
SCHEMBL3247679 0.81 NPC1 (0.49) L3MBTL1SLC22A12CCR4NPC1RAB9A
SCHEMBL5009144 0.79 LMNA (0.42) SLC22A12CCR4ALDH1A1CYP1A2CYP2C19
SCHEMBL302695 0.78 ALDH1A1 (0.53) SLC22A12NPC1RAB9AALDH1A1CYP1A2
SCHEMBL29965203 0.78 L3MBTL1 (0.61) L3MBTL1SLC22A12NPC1CYP1A2PKM
SCHEMBL2371550 0.78 L3MBTL1 (0.61) L3MBTL1SLC22A12NPC1CYP1A2PKM
SCHEMBL3555416 0.77 L3MBTL1 (0.51) L3MBTL1ALDH1A1LMNAHTR6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070071782-A1 2-Cyanobenzenesulfonamides for combating animal pests BASF AKTIENGESELLSCHAFT (DE) 2007-03-29 US disclosed
EP-1670752-A1 2-CYANOBENZENESULFONAMIDES FOR COMBATING ANIMAL PESTS BASF AKTIENGESELLSCHAFT (DE) 2006-06-21 EP disclosed
WO-2005035486-A1 2-CYANOBENZENESULFONAMIDES FOR COMBATING ANIMAL PESTS BASF AKTIENGESELLSCHAFT (DE) 2005-04-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070071782-A1 2-Cyanobenzenesulfonamides for combating animal pests MSR1, CHRM2, CBS L3MBTL1 211/4885SLC22A12 383/4885CCR4 1526/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.